Blockade Medical has obtained CE mark for its Barricade coil system, designed to remove or endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
The Barricade coil system, which includes a complete line of embolization coils, is available in ten and eighteen framing, filling and finishing coil configurations.
Blockade Medical chief executive officer Gibb Clarke said the use of platinum microcoils to treat intracranial aneurysms will continue to expand the neurovascular market.
"Coil embolization is the standard of care and is proven to be safe and effective for both ruptured and unruptured aneurysms," Clarke added.
"It is because of this safety and efficacy record that coil embolization will remain the standard of care in aneurysm treatment for years to come.
"The Barricade Coil System is our first product offering, which Blockade plans to complement with additional products in 2013."
Blockade Medical clinical advisor and Medical University of South Carolina endovascular neurosurgeon Raymond Turner said the Barricade coil system offered competitive performance in terms of deliverability, aneurysm conformability, filling and finishing.
"The framing coil allows me to frame and fill the aneurysm effectively while delivering coils without sacrificing catheter position," Turner added.
"The system also offers long filling and soft finishing coils to enable complete aneurysm embolization."